Weekly Recap | Amgen +4.25%, defensive bid amid tech pullbackWeekly Review·Oct 17, 2026 at 06:31 AMAMGN-1.34%
Weekly Recap | Amgen +2.94%, MariTide buzz lifts sharesWeekly Review·Oct 10, 2026 at 06:02 AMAMGN-1.34%
Weekly Recap | AMGN.US -2.79%, consensus target above spotWeekly Review·Oct 3, 2026 at 06:18 AMAMGN-1.34%
Weekly Recap | Amgen +7.51%, Phase 3 Sjogren's trial hits endpointWeekly Review·Sep 26, 2026 at 05:57 AMAMGN-1.34%
Weekly Recap | Amgen +2.2%, most brokers rate it holdWeekly Review·Sep 19, 2026 at 05:33 AMAMGN-1.34%
Weekly Recap | Amgen -13.7%, most brokers rate it holdWeekly Review·Sep 12, 2026 at 05:55 AMAMGN-1.34%
Weekly Recap | Amgen +1.11%, closing in on record highsWeekly Review·Sep 5, 2026 at 06:11 AMAMGN-1.34%
Weekly Recap | Amgen -1.57%, Tezspire Phase 3 hits endpointsWeekly Review·Aug 29, 2026 at 05:07 AMAMGN-1.34%
Weekly Recap | Amgen +5.81%, closing in on record highsWeekly Review·Aug 22, 2026 at 04:34 AMAMGN-1.34%
